Among them, there are two major signaling pathways: the dysregulation of Ras-mitogen-activated protein kinase signaling is responsible for the low grade of bladder cancer, and alteration of the cell cycle pathway is common in the invasive stage of bladder cancer [24]. The gene discussed is WNK2; the disease is urinary bladder carcinoma.